{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:30:18Z","timestamp":1760189418076},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T00:00:00Z","timestamp":1426204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s10552-015-0547-y","type":"journal-article","created":{"date-parts":[[2015,3,12]],"date-time":"2015-03-12T14:09:03Z","timestamp":1426169343000},"page":"601-608","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ovarian cancer survival by tumor dominance, a surrogate for site of origin"],"prefix":"10.1007","volume":"26","author":[{"given":"Anna","family":"Ivanova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anneli","family":"Loo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley","family":"Tworoger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher P.","family":"Crum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey","family":"Risch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Narod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Kotsopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,13]]},"reference":[{"issue":"10","key":"547_CR1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","volume":"11","author":"S Vaughan","year":"2011","unstructured":"Vaughan S, Coward JI, Bast RC Jr, Berchuck A, Berek JS, Brenton JD, Coukos G, Crum CC, Drapkin R, Etemadmoghadam D, Friedlander M, Gabra H, Kaye SB, Lord CJ, Lengyel E, Levine DA, McNeish IA, Menon U, Mills GB, Nephew KP, Oza AM, Sood AK, Stronach EA, Walczak H, Bowtell DD, Balkwill FR (2011) Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer 11(10):719\u2013725. doi: 10.1038\/nrc3144","journal-title":"Nat Rev Cancer"},{"issue":"24","key":"547_CR2","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","volume":"351","author":"SA Cannistra","year":"2004","unstructured":"Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351(24):2519\u20132529. doi: 10.1056\/NEJMra041842","journal-title":"N Engl J Med"},{"issue":"4","key":"547_CR3","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ijc.24038","volume":"124","author":"NM Velde van der","year":"2009","unstructured":"van der Velde NM, Mourits MJ, Arts HJ, de Vries J, Leegte BK, Dijkhuis G, Oosterwijk JC, de Bock GH (2009) Time to stop ovarian cancer screening in BRCA1\/2 mutation carriers? Int J Cancer 124(4):919\u2013923. doi: 10.1002\/ijc.24038","journal-title":"Int J Cancer"},{"key":"547_CR4","unstructured":"Barakat RR, Markman M, Randall ME (2009) Principles and practice of gynecologic oncology, 5th edn. Lippincott Williams and Wilkins, Baltimore"},{"issue":"Suppl. 2","key":"547_CR5","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/S0020-7292(12)60025-3","volume":"119","author":"JS Berek","year":"2012","unstructured":"Berek JS, Crum C, Friedlander M (2012) Cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 119(Suppl. 2):S118\u2013S129. doi: 10.1016\/S0020-7292(12)60025-3","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"547_CR6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/PAS.0b013e3181868904","volume":"33","author":"MH Roh","year":"2009","unstructured":"Roh MH, Kindelberger D, Crum CP (2009) Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin? Am J Surg Pathol 33(3):376\u2013383. doi: 10.1097\/PAS.0b013e3181868904","journal-title":"Am J Surg Pathol"},{"issue":"25","key":"547_CR7","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","volume":"26","author":"JW Carlson","year":"2008","unstructured":"Carlson JW, Miron A, Jarboe EA, Parast MM, Hirsch MS, Lee Y, Muto MG, Kindelberger D, Crum CP (2008) Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol 26(25):4160\u20134165. doi: 10.1200\/JCO.2008.16.4814","journal-title":"J Clin Oncol"},{"issue":"1","key":"547_CR8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","volume":"211","author":"Y Lee","year":"2007","unstructured":"Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, Garber J, Birch C, Mou H, Gordon RW, Cramer DW, McKeon FD, Crum CP (2007) A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 211(1):26\u201335. doi: 10.1002\/path.2091","journal-title":"J Pathol"},{"issue":"3","key":"547_CR9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ygyno.2009.01.013","volume":"113","author":"AK Folkins","year":"2009","unstructured":"Folkins AK, Jarboe EA, Roh MH, Crum CP (2009) Precursors to pelvic serous carcinoma and their clinical implications. Gynecol Oncol 113(3):391\u2013396. doi: 10.1016\/j.ygyno.2009.01.013","journal-title":"Gynecol Oncol"},{"issue":"12","key":"547_CR10","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","volume":"9","author":"L Dubeau","year":"2008","unstructured":"Dubeau L (2008) The cell of origin of ovarian epithelial tumours. Lancet Oncol 9(12):1191\u20131197. doi: 10.1016\/S1470-2045(08)70308-5","journal-title":"Lancet Oncol"},{"issue":"4","key":"547_CR11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/oxfordjournals.aje.a008937","volume":"144","author":"HA Risch","year":"1996","unstructured":"Risch HA, Marrett LD, Jain M, Howe GR (1996) Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case\u2013control study. Am J Epidemiol 144(4):363\u2013372","journal-title":"Am J Epidemiol"},{"issue":"2","key":"547_CR12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2559.2007.02938.x","volume":"53","author":"EA Jarboe","year":"2008","unstructured":"Jarboe EA, Folkins AK, Drapkin R, Ince TA, Agoston ES, Crum CP (2008) Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. Histopathology 53(2):127\u2013138. doi: 10.1111\/j.1365-2559.2007.02938.x","journal-title":"Histopathology"},{"issue":"2","key":"547_CR13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","volume":"30","author":"F Medeiros","year":"2006","unstructured":"Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, Garber JE, Cramer DW, Crum CP (2006) The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 30(2):230\u2013236","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"547_CR14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ijc.28064","volume":"133","author":"J Kotsopoulos","year":"2013","unstructured":"Kotsopoulos J, Terry KL, Poole EM, Rosner B, Murphy MA, Hecht JL, Crum CP, Missmer SA, Cramer DW, Tworoger SS (2013) Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin. Int J Cancer 133(3):730\u2013739. doi: 10.1002\/ijc.28064","journal-title":"Int J Cancer"},{"issue":"2","key":"547_CR15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2011.01.020","volume":"121","author":"S Zhang","year":"2011","unstructured":"Zhang S, Royer R, Li S, McLaughlin JR, Rosen B, Risch HA, Fan I, Bradley L, Shaw PA, Narod SA (2011) Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecol Oncol 121(2):353\u2013357. doi: 10.1016\/j.ygyno.2011.01.020","journal-title":"Gynecol Oncol"},{"issue":"3","key":"547_CR16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1399-0004.2012.01906.x","volume":"83","author":"SA Narod","year":"2013","unstructured":"Narod SA, Moody JR, Rosen B, Fan I, Risch A, Sun P, McLaughlin JR (2013) Estimating survival rates after ovarian cancer among women tested for BRCA1 and BRCA2 mutations. Clin Genet 83(3):232\u2013237. doi: 10.1111\/j.1399-0004.2012.01906.x","journal-title":"Clin Genet"},{"key":"547_CR17","first-page":"246","volume":"95","author":"EA Clarke","year":"1991","unstructured":"Clarke EA, Marrett LD, Kreiger N (1991) Cancer registration in Ontario: a computer approach. IARC Sci Publ 95:246\u2013257","journal-title":"IARC Sci Publ"},{"issue":"2","key":"547_CR18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jnci\/djs494","volume":"105","author":"JR McLaughlin","year":"2013","unstructured":"McLaughlin JR, Rosen B, Moody J, Pal T, Fan I, Shaw PA, Risch HA, Sellers TA, Sun P, Narod SA (2013) Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2. J Natl Cancer Inst 105(2):141\u2013148. doi: 10.1093\/jnci\/djs494","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"547_CR19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2105\/AJPH.79.3.340","volume":"79","author":"S Greenland","year":"1989","unstructured":"Greenland S (1989) Modeling and variable selection in epidemiologic analysis. Am J Public Health 79(3):340\u2013349","journal-title":"Am J Public Health"},{"issue":"3","key":"547_CR20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","volume":"34","author":"RJ Kurman","year":"2010","unstructured":"Kurman RJ, Shih Ie M (2010) The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 34(3):433\u2013443. doi: 10.1097\/PAS.0b013e3181cf3d79","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"547_CR21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc2946","volume":"10","author":"DD Bowtell","year":"2010","unstructured":"Bowtell DD (2010) The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer 10(11):803\u2013808. doi: 10.1038\/nrc2946","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"547_CR22","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2006.07.9970","volume":"26","author":"CN Landen Jr","year":"2008","unstructured":"Landen CN Jr, Birrer MJ, Sood AK (2008) Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol 26(6):995\u20131005. doi: 10.1200\/JCO.2006.07.9970","journal-title":"J Clin Oncol"},{"issue":"1","key":"547_CR23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","volume":"100","author":"A Finch","year":"2006","unstructured":"Finch A, Shaw P, Rosen B, Murphy J, Narod SA, Colgan TJ (2006) Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol 100(1):58\u201364. doi: 10.1016\/j.ygyno.2005.06.065","journal-title":"Gynecol Oncol"},{"issue":"2","key":"547_CR24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","volume":"31","author":"DW Kindelberger","year":"2007","unstructured":"Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, Callahan MJ, Garner EO, Gordon RW, Birch C, Berkowitz RS, Muto MG, Crum CP (2007) Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 31(2):161\u2013169. doi: 10.1097\/01.pas.0000213335.40358.47","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"547_CR25","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.AOG.0000187892.78392.3f","volume":"106","author":"I Cass","year":"2005","unstructured":"Cass I, Holschneider C, Datta N, Barbuto D, Walts AE, Karlan BY (2005) BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype? Obstet Gynecol 106(6):1327\u20131334. doi: 10.1097\/01.AOG.0000187892.78392.3f","journal-title":"Obstet Gynecol"},{"issue":"2","key":"547_CR26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","volume":"109","author":"AK Folkins","year":"2008","unstructured":"Folkins AK, Jarboe EA, Saleemuddin A, Lee Y, Callahan MJ, Drapkin R, Garber JE, Muto MG, Tworoger S, Crum CP (2008) A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. Gynecol Oncol 109(2):168\u2013173. doi: 10.1016\/j.ygyno.2008.01.012","journal-title":"Gynecol Oncol"},{"issue":"2","key":"547_CR27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molonc.2009.01.004","volume":"3","author":"CP Crum","year":"2009","unstructured":"Crum CP (2009) Intercepting pelvic cancer in the distal fallopian tube: theories and realities. Mol Oncol 3(2):165\u2013170. doi: 10.1016\/j.molonc.2009.01.004","journal-title":"Mol Oncol"},{"issue":"25","key":"547_CR28","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","volume":"25","author":"MJ Callahan","year":"2007","unstructured":"Callahan MJ, Crum CP, Medeiros F, Kindelberger DW, Elvin JA, Garber JE, Feltmate CM, Berkowitz RS, Muto MG (2007) Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol 25(25):3985\u20133990. doi: 10.1200\/JCO.2007.12.2622","journal-title":"J Clin Oncol"},{"issue":"7","key":"547_CR29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1701-2163(15)30894-X","volume":"35","author":"CJ Reade","year":"2013","unstructured":"Reade CJ, Finlayson S, McAlpine J, Tone AA, Fung-Kee-Fung M, Ferguson SE (2013) Risk-reducing salpingectomy in Canada: a survey of obstetrician-gynaecologists. J Obstet Gynaecol Can 35(7):627\u2013634","journal-title":"J Obstet Gynaecol Can"},{"issue":"4","key":"547_CR30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/modpathol.2011.183","volume":"25","author":"RA Soslow","year":"2012","unstructured":"Soslow RA, Han G, Park KJ, Garg K, Olvera N, Spriggs DR, Kauff ND, Levine DA (2012) Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma. Mod Pathol 25(4):625\u2013636. doi: 10.1038\/modpathol.2011.183","journal-title":"Mod Pathol"},{"key":"547_CR31","doi-asserted-by":"crossref","unstructured":"Howitt BE, Hanamornroongruang S, Lin DI, Conner JE, Schulte S, Horowitz N, Crum CP, Meserve EE (2015) Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma. Am J Surg Pathol 39(3):287\u2013293. doi: 10.1097\/PAS.0000000000000369","DOI":"10.1097\/PAS.0000000000000369"},{"issue":"6","key":"547_CR32","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1525-1438.2003.13602.x","volume":"13","author":"MA Bookman","year":"2003","unstructured":"Bookman MA, Greer BE, Ozols RF (2003) Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel vs. cisplatin and paclitaxel (GOG 158) and an update on GOG0 182-ICON5. Int J Gynecol Cancer 13(6):735\u2013740","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"547_CR33","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3322\/caac.20121","volume":"61","author":"R Siegel","year":"2011","unstructured":"Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61(4):212\u2013236. doi: 10.3322\/caac.20121","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"547_CR34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1701-2163(15)30659-9","volume":"36","author":"CJ Reade","year":"2014","unstructured":"Reade CJ, McVey RM, Tone AA, Finlayson SJ, McAlpine JN, Fung-Kee-Fung M, Ferguson SE (2014) The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift. J Obstet Gynaecol Can 36(2):133\u2013140","journal-title":"J Obstet Gynaecol Can"},{"key":"547_CR35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fonc.2014.00021","volume":"4","author":"T Schenberg","year":"2014","unstructured":"Schenberg T, Mitchell G (2014) Prophylactic bilateral salpingectomy as a prevention strategy in women at high-risk of ovarian cancer: a mini-review. Front Oncol 4:21. doi: 10.3389\/fonc.2014.00021","journal-title":"Front Oncol"},{"key":"547_CR36","author":"AP Finch","year":"2014","unstructured":"Finch AP, Lubinski J, Moller P, Singer CF, Karlan B, Senter L, Rosen B, Maehle L, Ghadirian P, Cybulski C, Huzarski T, Eisen A, Foulkes WD, Kim-Sing C, Ainsworth P, Tung N, Lynch HT, Neuhausen S, Metcalfe KA, Thompson I, Murphy J, Sun P, Narod SA (2014) Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. J Clin Oncol. doi: 10.1200\/JCO.2013.53.2820","journal-title":"J Clin Oncol"},{"issue":"3","key":"547_CR37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.maturitas.2011.08.001","volume":"70","author":"A Finch","year":"2011","unstructured":"Finch A, Narod SA (2011) Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: a review. Maturitas 70(3):261\u2013265. doi: 10.1016\/j.maturitas.2011.08.001","journal-title":"Maturitas"},{"issue":"3","key":"547_CR38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ygyno.2013.04.021","volume":"129","author":"CB Gilks","year":"2013","unstructured":"Gilks CB, Miller D (2013) Opportunistic salpingectomy for women at low risk for development of ovarian carcinoma: the time has come. Gynecol Oncol 129(3):443\u2013444. doi: 10.1016\/j.ygyno.2013.04.021","journal-title":"Gynecol Oncol"},{"issue":"1","key":"547_CR39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2013.07.086","volume":"131","author":"G Hofstetter","year":"2013","unstructured":"Hofstetter G, Concin N, Braicu I, Chekerov R, Sehouli J, Cadron I, Van Gorp T, Trillsch F, Mahner S, Ulmer H, Grimm C, Castillo-Tong DC, Zeillinger R, Zeimet AG, Vergote I (2013) The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma\u2014analysis of patient data in the prospective OVCAD study. Gynecol Oncol 131(1):15\u201320. doi: 10.1016\/j.ygyno.2013.07.086","journal-title":"Gynecol Oncol"},{"issue":"5","key":"547_CR40","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","volume":"164","author":"M Shih Ie","year":"2004","unstructured":"Shih Ie M, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164(5):1511\u20131518","journal-title":"Am J Pathol"},{"issue":"2","key":"547_CR41","first-page":"151","volume":"27","author":"RJ Kurman","year":"2008","unstructured":"Kurman RJ, Shih Ie M (2008) Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 27(2):151\u2013160. doi: 10.1097\/PGP.0b013e318161e4f5","journal-title":"Int J Gynecol Pathol"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-015-0547-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-015-0547-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-015-0547-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T13:06:38Z","timestamp":1559221598000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-015-0547-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,13]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["547"],"URL":"https:\/\/doi.org\/10.1007\/s10552-015-0547-y","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,13]]}}}